New drug shows promise for tough bladder cancer cases
NCT ID NCT05226117
First seen Apr 07, 2026 · Last updated May 13, 2026 · Updated 7 times
Summary
This study tested a drug called sacituzumab govitecan in 44 people with muscle-invasive bladder cancer who could not take or refused standard cisplatin chemotherapy. The drug was given before surgery to remove the bladder, aiming to wipe out all cancer cells. The main goal was to see if the drug could lead to a complete response, meaning no cancer left in the removed bladder tissue.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UROTHELIAL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
IRCCS Ospedale San Raffaele
Milan, 20132, Italy
Conditions
Explore the condition pages connected to this study.